FDCBSEFDC LIMITED· Pharmaceuticals & BiotechnologyHighPositive
Announced Tue, 27 Oct, 2026 · 19:39 IST

FDC sets November 13 record date for Rs 120 crore share buyback

FDC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+6.8%Reaction day
₹353.00
prior close
₹385.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+6.7% vs market
Pharmaceuticals peers, median of 170sector+0.6%+6.2% vs sector

On the reaction day the stock moved 6.7 pts more than Nifty Microcap 250 and 6.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.8
10m
-4.3
15m
-4.2
30m
-3.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+6.8+0.1+6.7+0.6+6.2
Next day
+6.8+0.7+6.1+1.1+5.7
2d
+7.1pendingpending-0.3+7.3
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

FDC's board approved buying back up to 24 lakh shares, equal to 1.47% of paid-up capital, at Rs 500 per share through a tender offer for up to Rs 120 crore. November 13, 2026 is the record date, and promoters plan to participate. For the September 2026 quarter, consolidated revenue was Rs 572.14 crore and profit after tax was Rs 49.06 crore, against Rs 473.03 crore and Rs 28.37 crore a year earlier.

Likely market impact

The buyback may support the share price and lift earnings per share, but the 1.47% size limits the effect. Up to Rs 120 crore of cash will be used, reducing reserves.